Clinical trials
Terminated Observational Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
137 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 4 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 3 |
| 2006 | 5 |
| 2007 | 3 |
| 2008 | 5 |
| 2009 | 10 |
| 2010 | 7 |
| 2011 | 3 |
| 2012 | 9 |
| 2013 | 1 |
| 2014 | 7 |
| 2015 | 7 |
| 2016 | 6 |
| 2017 | 8 |
| 2018 | 12 |
| 2019 | 11 |
| 2020 | 10 |
| 2021 | 9 |
| 2022 | 5 |
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 137 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 8 |
| Stanford University | 4 |
| University of New Mexico | 4 |
| Indiana University | 3 |
| National Institutes of Health Clinical Center (CC) | 3 |
| Wake Forest University Health Sciences | 3 |
| AbbVie | 2 |
| Centre Francois Baclesse | 2 |
| Centre Hospitalier Universitaire de Saint Etienne | 2 |
| Columbia University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 137 |
| Breast Neoplasms | 16 |
| Lung Neoplasms | 9 |
| Melanoma | 9 |
| Colorectal Neoplasms | 8 |
| Brain Neoplasms | 5 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 5 |
| Lymphoma | 5 |
| Multiple Myeloma | 5 |
| COVID-19 | 4 |
Trials
Showing 1 to 25 of 137. Each trial links to its page on Pharma Observatory.
37 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.